日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MIF-mediated crosstalk between THRSP + hepatocytes and CD74 + lipid-associated macrophages in hepatic periportal zone drives MASH

肝门周区中THRSP+肝细胞与CD74+脂质相关巨噬细胞之间由MIF介导的相互作用驱动MASH

Xu, Xu; Li, Huagen; Lin, Hai; Li, Qichao; Liu, Yuenan; Huang, Weijun; Yang, Jundong; Li, Niannian; Gao, Zhenfei; Wang, Shengming; Shen, Hangdong; Xue, Wenjun; Yuan, Haolin; Wang, Wei; Shuai, Jianwei; Liu, Junli; Yin, Shankai; Liu, Feng

HRS Degradation-Induced Nicotinamide Deficiency in Placental Extracellular Vesicles Triggers Preeclampsia by Disrupting Maternal-Fetal Immune Homeostasis

HRS降解诱导的胎盘细胞外囊泡烟酰胺缺乏通过破坏母胎免疫稳态引发先兆子痫

Fei, Haiyi; Lin, Yuhan; Liu, Xiu; Zhu, Xiaohong; Lu, Xiaowen; Shi, Zhan; Jia, Fan; Xu, Shiqian; Fang, Ling; Jiang, Lingling; Zhang, Songying

Discovery of a novel Nrf2 activator that modulates mitochondrial function in neurons by regulating DHRS3-Nrf2 interaction after ischemic stroke.

发现一种新型 Nrf2 激活剂,可通过调节缺血性中风后 DHRS3-Nrf2 相互作用来调节神经元中的线粒体功能。

Sun Xiaohui, Liu Zhaofeng, An Huanhuan, Xu Hengwei, Zou Fangxia, Lu Jing, Zhang Xiaofan, Han Xinyu, Song Ziwei, Sun Yanli, Wang Wenyan, Wang Hongbo, Zhang Jianzhao, Wang Yunjie, Tian Jingwei

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody.

抗核蛋白 hRSV 单克隆抗体的保护能力的临床前表征。

Farías Mónica A, Andrade Catalina A, Loaiza Ricardo A, Rodríguez-Guilarte Linmar, Muñoz José T, Pereira-Sánchez Patricia, Muñoz-Durango Natalia, Pizarro-Ortega Magdalena S, Diethelm-Varela Benjamín, Pereira-Serrano Alejandra, Ramírez Robinson A, Chávez José L, Bohmwald Karen, Soto Jorge A, González Pablo A, Bueno Susan M, Kalergis Alexis M

Letter to the Editor about Dynamic patterns of depression and their association with stroke: insights from CHARLS, ELSA, and HRS

致编辑的信:关于抑郁症动态模式及其与中风的关联:来自 CHARLS、ELSA 和 HRS 的见解

Shi, Yan; Pan, Peng; Ping, Liangliang; Wang, Junwen

Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRS

幼稚CD4+ T淋巴细胞的特异性缺乏是心力衰竭的特征,并会增加HRS患者的死亡风险。

Zidar, David A; Freeman, Michael L; Wilson, Brigid M; Al-Kindi, Sadeer; Chung, Mina K; Gunzler, Douglas D; Parikh, Sahil A; Sharma, Ashish A; Shive, Carey L; Jain, Mukesh; Skarbinski, Jacek; Tang, W H Wilson; Dalton, Jarrod E; Anthony, Donald D; Chan, Timothy A; Thyagarajan, Bharat

Synergistic anticancer effects of cabozantinib and cuproptosis induction driven by DHRS2-KAT2A-H3K27ac axis in clear cell renal cell carcinoma

卡博替尼与DHRS2-KAT2A-H3K27ac轴驱动的铜凋亡诱导在透明细胞肾细胞癌中具有协同抗癌作用

Cao, Yilong; Xu, Chao; Zhang, Bowei; Qu, Changbao; Liu, Yuepeng; Shi, Bei; Li, Xiaoling; Li, Jiehan; Zhang, Zeyuan; Dai, Shengtao; Sun, Qingyun; Wang, Yaxuan; Gu, Junfei

Effects of renal impairment and hemodialysis on the pharmacokinetics and safety of HRS-8427, a siderophore cephalosporin for Gram-negative bacterial infections

肾功能损害和血液透析对铁载体头孢菌素类药物HRS-8427(用于治疗革兰氏阴性菌感染)的药代动力学和安全性的影响

Wu, Yuanhao; Han, Qiwen; Yang, Haijing; Xue, Jun; Wang, Lili; Mao, Xiaomeng; Yin, Tengrui; Jiang, Hao; Xu, Sheng; Huang, Yuanyuan; Wang, Ting; He, Yan; Luo, Yuanyuan; Chen, Wenli; Zhang, Jing

Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects

在健康受试者中,新型抗碳青霉烯类耐药头孢菌素HRS-8427的药代动力学、安全性和耐受性研究

Yin, Tengrui; Qu, Biao; Zhang, Qian; Xu, Sheng; Wu, Yijue; Jiang, Hao; Huang, Yuanyuan; Hu, Wei

Put the CAR-T before the HRS: Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma

先进行 CAR-T 疗法,再进行 HRS 疗法:靶向经典霍奇金淋巴瘤中霍奇金/里德-斯滕伯格细胞的抗 CD30 免疫疗法的进展

Mayasin, Yuriy; Osinnikova, Maria; Osadchaya, Daria; Dmitrienko, Victoria; Gorodilova, Anna; Kharisova, Chulpan; Kitaeva, Kristina; Solovyeva, Valeria; Rizvanov, Albert